NRG Therapeutics has appointed Paul Thompson as its new Chief Development Officer, who brings specialist expertise in neurology to his new role. Thompson's experience includes translational research and early clinical development.
Who to call at NRG Therapeutics, and when
A new leader at NRG Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day NRG Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at NRG Therapeutics, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
NRG Therapeutics
Location
Stevenage, England, United Kingdom
About
NRG Therapeutics is a neuroscience drug discovery company building a pipeline of disease-modifying mitochondrial therapeutics to slow or halt the progression of neurodegenerative disorders such as Parkinson's and Amyotrophic Lateral Sclerosis (ALS), also known as motor neurone disease (MND).
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NRG Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
StevenageBiotechnologyHealth CareTherapeutics